A single lab result is sending women in their 20s and 30s into a fertility panic — and directing them straight into the egg-freezing consultation rooms of clinics that profit from their fear. AMH, or anti-Müllerian hormone, is one of the most commercially marketed fertility tests available. And its implications are being consistently misrepresented to millions of women.
In this episode of Cycle Wisdom, Dr. Monica Minjeur, DO sets the record straight on what AMH actually measures, what it does not predict, and why egg freezing should never be the reflexive first response to a low result. Through Isabelle's story — a 29-year-old who came to us convinced she was running out of time after an at-home test flagged her AMH as low — you will see how accurate clinical context changes everything.
You will learn:
What AMH actually measures and what it does not — including why a 2013 landmark study found that low AMH in women under 35 with regular cycles did not reduce natural conception rates over 12 months
The real data on egg freezing success rates — and why the conversation most clinics are having with women is incomplete
What a complete ovarian reserve evaluation actually looks like and what treatment options exist for women with genuinely low AMH
If a low AMH result has sent you into panic mode — this episode will give you the accurate clinical context you deserved from the beginning. Learn more or schedule a free discovery call at radiantclinic.com.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Monica Minjeur. Innehållet i podden är skapat av Dr. Monica Minjeur och inte av,
eller tillsammans med, Poddtoppen.
